Tags: Johnson & Johnson

Pharmacyclics May Soon Be Acquired by Johnson & Johnson for $18 Billion

Pharmacyclics will ‘possibly’ be acquired by Johnson & Johnson for $18 Billion Pharmacyclics, the US-based biopharmaceutical organization that develops and commercializes small-molecule drugs for cancer and other diseases, surged to a new high when Bloomberg reported that the company is considering selling itself for $18 billion.
1 2

Recommended Stories

Real Time Analytics